CALM3 mutation associated with long QT syndrome

  • Heart Rhythm. 2015 Feb;12(2):419-22. doi: 10.1016/j.hrthm.2014.10.035.
Griffin J Reed  1 ,  Nicole J Boczek  2 ,  Susan P Etheridge  3 ,  Michael J Ackerman  4
Affiliations
  • 1. Department of Molecular Pharmacology and Experimental Therapeutics, Windland Smith Rice Sudden Death Genomics Laboratory.
  • 2. Department of Molecular Pharmacology and Experimental Therapeutics, Windland Smith Rice Sudden Death Genomics Laboratory; Center for Clinical and Translational Science; Mayo Graduate School, Mayo Clinic, Rochester, Minnesota.
  • 3. Primary Children's Hospital, Salt Lake City, Utah.
  • 4. Department of Molecular Pharmacology and Experimental Therapeutics, Windland Smith Rice Sudden Death Genomics Laboratory; Division of Cardiovascular Diseases, Department of Medicine; Division of Pediatric Cardiology, Department of Pediatrics, Mayo Clinic, Rochester, Minnesota. Electronic address: [email protected].
PMID: 25460178 DOI: 10.1016/j.hrthm.2014.10.035
Keywords
Arrhythmia; CALM3; Calcium channel inactivation; Calmodulin; Genetics; Long QT syndrome.